Skip to main content
. 2018 Jan 19;9:6. doi: 10.3389/fphys.2018.00006

Figure 5.

Figure 5

Bumetanide and TGN-020 inhibited SCI-induced upregulation of AQP4 and NKCC1. (A) The mRNA levels of AQP4 and NKCC1 of rat spinal cord 48 h after SCI were analyzed by qPCR. (B) The changes of AQP4 and NKCC1 protein levels in rat spinal cord 48 h after SCI with or without TGN-020 and/or bumetanide treatment were assessed by western blot. (C) Quantitative analysis of AQP4 and NKCC1 protein levels in SCI rats after TGN-020 and/or bumetanide treatments. (D) Histoimmunofluorescence detection of changes of AQP4 (green) and NKCC (red) protein levels of injured rat spinal cord tissue treated with TGN-020 and/ or bumetanide (scale bar 50 μm). NC, normal control (uninjured spinal cords); BU, bumetanide; TGN, TGN-020. N = 7. *p < 0.05 compared to NC; #p < 0.05 compared to SCI; ˆp < 0.05 compared to BU; +p < 0.05 compared to TGN.